Literature DB >> 5588188

Alpha-methyl-p-tyrosine (AMT) in schizophrenia.

S Gershon, L J Hekimian, A Floyd, L E Hollister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5588188     DOI: 10.1007/BF00401257

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  10 in total

1.  CLINICAL CASE REPORT FORMS. CLINICAL CASE REPORT FORMS FOR PSYCHOPHARMACOLOGY RESEARCH; PSYCHOPHARMACOLOGY RESEARCH UNIT N.Y.U.-BELLEVUE MEDICAL CENTER.

Authors:  V A PLACE
Journal:  J New Drugs       Date:  1964 Jul-Aug

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE.

Authors:  S SPECTOR; A SJOERDSMA; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1965-01       Impact factor: 4.030

4.  A simple analysis for normetanephrine and metanephrine in urine.

Authors:  J J PISANO
Journal:  Clin Chim Acta       Date:  1960-05       Impact factor: 3.786

5.  Determination of 3-methoxy-4-hydroxymandelic acid in urine.

Authors:  J J PISANO; J R CROUT; D ABRAHAM
Journal:  Clin Chim Acta       Date:  1962-03       Impact factor: 3.786

Review 6.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

7.  Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase.

Authors:  A Sjoerdsma; K Engelman; S Spector; S Udenfriend
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

8.  The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse.

Authors:  C C Porter; J A Totaro; A Burcin; E R Wynosky
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

9.  THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.

Authors:  A C GREINER; G A NICOLSON; R A BAKER
Journal:  Can Med Assoc J       Date:  1964-09-19       Impact factor: 8.262

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
  10 in total
  3 in total

1.  Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.

Authors:  A Carlsson; T Persson; B E Roos; J Wålinder
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

2.  Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.

Authors:  A Carlsson; B E Roos; J Wålinder; A Skott
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

3.  Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools.

Authors:  M Larsson; R Ohman; L Wallin; J Wålinder; A Carlsson
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.